Olivier Danos, Ph.D., has been named senior vice president of Gene Therapy at Biogen Idec. Dr. Danos reports to Douglas Williams, Ph.D., executive vice president, R&D, and is a member of Biogen’s senior R&D leadership team.   Dr. Danos will lead the company’s gene therapy research group and will also identify potential collaborations that complement the company’s internal capabilities and support the development of treatments across Biogen’s therapeutic focus areas.   Dr. Danos joins the...